Osteopontin and Protein Kinase C Regulate PDLIM2 Activation and STAT1 Ubiquitination in LPS-treated Murine Macrophages
Overview
Affiliations
The molecular pathways regulating signal transducer and activator of transcription 1 (STAT1) levels in states of inflammation are incompletely understood. The suppressor of cytokine signaling, protein inhibitor of STAT, and SHP-1/2 tyrosine phosphatases ultimately regulate activity of STAT molecules. However, these mechanisms do not degrade STAT proteins. In this regard, using a murine macrophage model of LPS stimulation, we previously demonstrated that osteopontin (OPN) increased STAT1 ubiquitination and 26 S proteasome degradation via the ubiquitin E3 ligase, PDLIM2. In this study, we further characterize OPN-dependent activation of PDLIM2 in a model of LPS-stimulated RAW264.7 murine macrophages. We identify serine 137 as a protein kinase C-phosphorylation site in PDLIM2 that is required for ubiquitination of STAT1. PDLIM2 phosphorylation requires OPN expression. Using phospho-mutants and phospho-mimetic constructs of PDLIM2, our in vivo and in vitro ubiquitination studies confirm the role of PDLIM2 in formation and degradation of Ub-STAT1. The functional consequences of PDLIM2-mediated STAT1 degradation were confirmed using an IFN-γ-regulated transcription factor STAT1α reporter construct and chromatin immunoprecipitation assay for the inducible nitric-oxide synthase promoter. In a murine cecal ligation and puncture model of sepsis in wild-type and OPN (-/-) animals, OPN was necessary for PDLIM2 serine phosphorylation and STAT1 ubiquitination in bone marrow macrophages. We conclude that OPN and PDLIM2 are important regulators of STAT1-mediated inflammatory responses.
Contributions of Ubiquitin and Ubiquitination to Flaviviral Antagonism of Type I IFN.
Hay-McCullough E, Morrison J Viruses. 2021; 13(5).
PMID: 33925296 PMC: 8145522. DOI: 10.3390/v13050763.
BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization.
Zhang D, Pan Z, Yu X, Chen Y, Gao C, Yang Y J Immunol Res. 2020; 2019:4657928.
PMID: 31930149 PMC: 6942849. DOI: 10.1155/2019/4657928.
Joyce M, Berry-Wynne K, Dos Santos T, Addison W, McFarlane N, Hobman T PLoS Pathog. 2019; 15(8):e1007949.
PMID: 31374104 PMC: 6677295. DOI: 10.1371/journal.ppat.1007949.
Bortell N, Flynn C, Conti B, Fox H, Marcondes M Mediators Inflamm. 2017; 2017:7582437.
PMID: 28811681 PMC: 5547729. DOI: 10.1155/2017/7582437.
Ren Y, Zhao P, Liu J, Yuan Y, Cheng Q, Zuo Y PLoS Pathog. 2016; 12(7):e1005764.
PMID: 27434509 PMC: 4951015. DOI: 10.1371/journal.ppat.1005764.